𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quality of life in patients with K- RAS wild-type colorectal cancer

✍ Scribed by Ringash, Jolie; Au, Heather-Jane; Siu, Lillian L.; Shapiro, Jeremy D.; Jonker, Derek J.; Zalcberg, John R.; Moore, Malcolm J.; Strickland, Andrew; Kotb, Rami; Jeffery, Mark; Alcindor, Thierry; Ng, Siobhan; Salim, Muhammad; Sabesan, Sabe; Easaw, Jay C.; Shannon, Jenny; El-Tahche, Fabyolla; Walters, Ian; Tu, Dongsheng; O'Callaghan, Christopher J.

Book ID
125449573
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
336 KB
Volume
120
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Insulin-like growth factor 1 expression
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan
✍ Mario Scartozzi; Alessandra Mandolesi; Riccardo Giampieri; Chiara Pierantoni; Fo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 245 KB

## Abstract Seventy to 40% of K‐RAS wild type colorectal tumors does not seem to benefit from treatment with antiepidermal growth factor receptor (anti‐EGFR) monoclonal antibodies. Recent data suggested that in presence of IGF‐1 system, altered activation colorectal cancer cells may escape anti‐EGF

Quality of life in colorectal cancer
Quality of life in colorectal cancer
✍ M. A. G. Sprangers; B. G. Taal; N. K. Aaronson; A. te Velde πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 828 KB